SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Pregnancy Vitamin D Supplementation and Childhood Bone Mass at Age 4 Years: Findings From the Maternal Vitamin D Osteoporosis Study (MAVIDOS) Randomized Controlled Trial.

Curtis, EM; Moon, RJ; D'Angelo, S; Crozier, SR; Bishop, NJ; Gopal-Kothandapani, JS; Kennedy, SH; Papageorghiou, AT; Fraser, R; Gandhi, SV; et al. Curtis, EM; Moon, RJ; D'Angelo, S; Crozier, SR; Bishop, NJ; Gopal-Kothandapani, JS; Kennedy, SH; Papageorghiou, AT; Fraser, R; Gandhi, SV; Schoenmakers, I; Prentice, A; Inskip, HM; Godfrey, KM; Javaid, MK; Eastell, R; Cooper, C; Harvey, NC; MAVIDOS Trial Group (2022) Pregnancy Vitamin D Supplementation and Childhood Bone Mass at Age 4 Years: Findings From the Maternal Vitamin D Osteoporosis Study (MAVIDOS) Randomized Controlled Trial. JBMR Plus, 6 (7). e10651. ISSN 2473-4039 https://doi.org/10.1002/jbm4.10651
SGUL Authors: Papageorghiou, Aris

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution.

Download (756kB) | Preview
[img] Microsoft Word (.docx) (Supplementary tables) Published Version
Available under License Creative Commons Attribution.

Download (39kB)

Abstract

In the Maternal Vitamin D Osteoporosis Study (MAVIDOS) randomized trial, vitamin D supplementation in pregnancy did not lead to greater neonatal bone mass across the trial as a whole, but, in a prespecified secondary analysis by season of birth, led to greater neonatal bone mass among winter-born babies. Demonstrating persistence of this effect into childhood would increase confidence in a long-term benefit of this intervention. We investigated whether antenatal vitamin D supplementation increases offspring bone mineralization in early childhood in a prespecified, single-center follow-up of a double-blinded, multicenter, randomized controlled clinical trial based in the UK (MAVIDOS). A total of 1123 women in early pregnancy with a baseline 25-hydroxyvitamin D level 25-100 nmol/L from three research centers (2008-2014) were randomized to 1000 IU/d cholecalciferol or matched placebo from 14 weeks of gestation to delivery. Offspring born at the Southampton, UK research center were assessed at age 4 years (2013-2018). Anthropometry and dual-energy X-ray absorptiometry (DXA) were performed (yielding whole body less head [WBLH] bone mineral content [BMC], areal bone mineral density [aBMD], bone area [BA], and body composition). Of 723 children, 564 (78.0%) children attended the 4-year visit, 452 of whom had a useable DXA. Maternal vitamin D supplementation led to greater WBLH aBMD in the children compared with placebo (mean [95% confidence interval {CI}]: supplemented group: 0.477 (95% CI, 0.472-0.481) g/cm2; placebo group: 0.470 (95% CI, 0.466-0.475) g/cm2, p = 0.048). Associations were consistent for BMC and lean mass, and in age- and sex-adjusted models. Effects were observed across the whole cohort irrespective of season of birth. Maternal-child interactions were observed, with a greater effect size among children with low milk intake and low levels of physical activity. Child weight, height, and body mass index (BMI) were similar by maternal randomization group. These findings suggest a sustained beneficial effect of maternal vitamin D supplementation in pregnancy on offspring aBMD at age 4 years, but will require replication in other trials. © 2022 The Authors. JBMR Plus published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research.

Item Type: Article
Additional Information: © 2022 The Authors. JBMR Plus published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research. This is an open access article under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Keywords: CLINICAL TRIALS, DXA, FRACTURE PREVENTION, NUTRITION, OSTEOPOROSIS, MAVIDOS Trial Group, CLINICAL TRIALS, DXA, FRACTURE PREVENTION, NUTRITION, OSTEOPOROSIS
SGUL Research Institute / Research Centre: Academic Structure > Institute of Medical & Biomedical Education (IMBE)
Academic Structure > Institute of Medical & Biomedical Education (IMBE) > Centre for Clinical Education (INMECE )
Journal or Publication Title: JBMR Plus
ISSN: 2473-4039
Language: eng
Dates:
DateEvent
18 July 2022Published
11 June 2022Published Online
28 April 2022Accepted
Publisher License: Creative Commons: Attribution 4.0
Projects:
Project IDFunderFunder ID
17702Arthritis Research UKUNSPECIFIED
405050259Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
U105960371Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
201268/Z/16/ZWellcome Trusthttp://dx.doi.org/10.13039/100004440
289346Seventh Framework Programmehttp://dx.doi.org/10.13039/501100004963
613977Seventh Framework Programmehttp://dx.doi.org/10.13039/501100004963
BB/P028179/1Biotechnology and Biological Sciences Research Councilhttp://dx.doi.org/10.13039/501100000268
696295Horizon 2020http://dx.doi.org/10.13039/501100007601
PubMed ID: 35866154
Web of Science ID: WOS:000809397800001
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/114753
Publisher's version: https://doi.org/10.1002/jbm4.10651

Actions (login required)

Edit Item Edit Item